Plain-English translation of NCT07185815 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Schizophrenia research guide →Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This study is testing a new way to deliver a psychiatric medication called cariprazine—as a once-monthly injection under the skin instead of a daily pill. The trial will look at how safe the medication is, how well it works, and how your body processes it. Researchers want to see if this longer-acting form could be easier for people to use while managing their condition.
Many people with schizophrenia, bipolar disorder, or depression struggle to take daily pills consistently, which can make their symptoms worse. This trial exists to see if a monthly injection might make treatment easier to stick with and help more people stay stable.
You likely qualify if…
You likely don't qualify if…
You would receive monthly injections under your skin at a clinic, starting with a small dose that may gradually increase as the study continues. The research team will monitor you regularly through blood tests, safety check-ins, and symptom assessments to see how you're doing. The study includes about 24 people across multiple clinics, and you'd be part of one of three groups depending on your diagnosis and treatment history.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
India
Israel